Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001213900-20-010404
Filing Date
2020-04-29
Accepted
2020-04-29 13:36:19
Documents
3
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A f10k2019a1_tffpharma.htm 10-K/A 173588
2 CERTIFICATION UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. f10k2019ex31-1_tffpharma.htm EX-31.1 2951
3 CERTIFICATION UNDER SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002. f10k2019ex31-2_tffpharma.htm EX-31.2 3104
  Complete submission text file 0001213900-20-010404.txt   180633
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

EIN.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-39102 | Film No.: 20829077
SIC: 2834 Pharmaceutical Preparations